For Healthcare Professionals:
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma UK. If you have any further questions, please contact Orion Pharma on 01635 520300 or at our office address.
The following pharmaceutical products of Orion are marketed in the UK by Orion Pharma (UK) Ltd:
Medicines approved within the UK may also be approved for Great Britain and Northern Ireland separately. The Great Britain medicines information is hosted on the Electronic Medicines Compendium (eMC) webpage. and the Northern Ireland medicines information is hosted on at: https://www.emcmedicines.com/en-gb/northernireland/company?id=99
Prescription drugs and self-care products
Please visit our corporate site for more information about Orion's prescription drugs and the Global portfolio.
JUNE 2022 / CORP-208c(2)
This information is intended for UK healthcare professionals only. This site contains promotional information. Click yes to enter the HCP site. Click no to be taken to the public site.